A Trial to Evaluate the Safety and Efficacy of a Fully Degradable Ventricular Septal Defect (VSD) Closure
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 108 participants.
Also called NCT03941691
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 108 participants
- Registry
-
NCT03941691
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT03941691. Randomized; no masking; primary purpose treatment. Start 2019-04-11 (actual); primary completion 2021-04-20 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Trial to Evaluate the Safety and Efficacy of a Fully Degradable Ventricular Septal Defect (VSD) Closure
- Condition
- Ventricular Septal Defect
- Intervention (Device)
- Fully Absorbable VSD Occlusion System
- Intervention (Device)
- VSD Occluder
- Lead sponsor
- Chinese Academy of Medical Sciences, Fuwai Hospital
- Collaborator
- Shanghai Shape Memory Alloy Co., Ltd.
Record details
- Record id
cardio:ct-nct03941691- Content hash
fa16e292b4ade47feec9916957c123b916fc8b76ba23acbb039cf53c68718d0b